5 results on '"CRESCIMANNO, Marilena"'
Search Results
2. On the role of cystatin C in cancer progression.
- Author
-
Leto, Gaetano, Crescimanno, Marilena, and Flandina, Carla
- Subjects
- *
CYSTATINS , *CANCER invasiveness , *COCARCINOGENS , *TUMOR suppressor genes , *PROTEINASES - Abstract
Cystatin C (Cyst C) is an endogenous inhibitor of lysosomal cysteine proteinases, which has been shown to play a role in several normal and pathological processes. Interestingly, a growing number of experimental and clinical studies suggest that this inhibitor also appears to be implicated in the malignant progression of various human tumors. However, the role of Cyst C in malignant diseases is still controversial as these studies have highlighted that this protein may function either as tumor suppressor or tumor promoter. The specific mechanisms underlying these opposing effects at present remain murky and are the subject of many current investigations. On the other hand, a complete knowledge of these mechanisms is of clinical interest in order to develop new, effective antitumor treatments based on the appropriate use of natural and/or synthetic cysteine proteinase inhibitors. This paper discusses the current findings regarding the role of Cyst C in cancer progression and the clinical implications emerging from these studies. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
3. Effects of oleuropein on tumor cell growth and bone remodelling: Potential clinical implications for the prevention and treatment of malignant bone diseases.
- Author
-
Leto, Gaetano, Flandina, Carla, Crescimanno, Marilena, Giammanco, Marco, and Sepporta, Maria Vittoria
- Subjects
- *
BONE diseases , *BONE growth , *BONE remodeling , *TUMOR growth , *CELL growth , *NEOVASCULARIZATION - Abstract
Oleuropein (Ole) is the main bioactive phenolic compound present in olive leaves, fruits and olive oil. This molecule has been shown to exert beneficial effects on several human pathological conditions. In particular, recent preclinical and observational studies have provided evidence that Ole exhibits chemo-preventive effects on different types of human tumors. Studies undertaken to elucidate the specific mechanisms underlying these effects have shown that this molecule may thwart several key steps of malignant progression, including tumor cell proliferation, survival, angiogenesis, invasion and metastasis, by modulating the expression and activity of several growth factors, cytokines, adhesion molecules and enzymes involved in these processes. Interestingly, experimental observations have highlighted the fact that most of these signalling molecules also appear to be actively involved in the homing and growth of disseminating cancer cells in bones and, ultimately, in the development of metastatic bone diseases. These findings, and the experimental and clinical data reporting the preventive activity of Ole on various pathological conditions associated with a bone loss, are indicative of a potential therapeutic role of this molecule in the prevention and treatment of cancer-related bone diseases. This paper provides a current overview regarding the molecular mechanisms and the experimental findings underpinning a possible clinical role of Ole in the prevention and development of cancer-related bone diseases. Unlabelled Image • Oleuropein, a phenolic compound present in olive leaves and fruits, exerts beneficial effects against various human diseases including cancer. • This compounds may thwart cancer progression by modulating the expression and activity of several molecular pathways fostering this process. • Most of these pathways also appear to favour the homing and growth of disseminating cancer cells in bones. • These findings suggest a potential therapeutic role of Oleuropein in the prevention and treatment of bone tumors. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
4. Effects of oleuropein on tumor cell growth and bone remodelling: Potential clinical implications for the prevention and treatment of malignant bone diseases
- Author
-
Carla Flandina, Marilena Crescimanno, Gaetano Leto, Maria Vittoria Sepporta, Marco Giammanco, Leto, Gaetano, Flandina, Carla, Crescimanno, Marilena, Giammanco, Marco, and Sepporta, Maria Vittoria
- Subjects
0301 basic medicine ,Angiogenesis ,Iridoid Glucosides ,Metastasi ,Chemoprevention ,030226 pharmacology & pharmacy ,General Biochemistry, Genetics and Molecular Biology ,Metastasis ,Bone remodeling ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Oleuropein ,medicine ,Animals ,Humans ,Iridoids ,General Pharmacology, Toxicology and Pharmaceutics ,Bone ,Cancer ,Cell Proliferation ,business.industry ,Cell adhesion molecule ,Polyphenols ,General Medicine ,medicine.disease ,Tumor progression ,030104 developmental biology ,Cellular Microenvironment ,chemistry ,Bone metastasi ,Cancer cell ,Settore BIO/14 - Farmacologia ,Disease Progression ,Cancer research ,Bone Remodeling ,Bone Diseases ,business ,Homing (hematopoietic) - Abstract
Oleuropein (Ole) is the main bioactive phenolic compound present in olive leaves, fruits and olive oil. This molecule has been shown to exert beneficial effects on several human pathological conditions. In particular, recent preclinical and observational studies have provided evidence that Ole exhibits chemo-preventive effects on different types of human tumors. Studies undertaken to elucidate the specific mechanisms underlying these effects have shown that this molecule may thwart several key steps of malignant progression, including tumor cell proliferation, survival, angiogenesis, invasion and metastasis, by modulating the expression and activity of several growth factors, cytokines, adhesion molecules and enzymes involved in these processes. Interestingly, experimental observations have highlighted the fact that most of these signalling molecules also appear to be actively involved in the homing and growth of disseminating cancer cells in bones and, ultimately, in the development of metastatic bone diseases. These findings, and the experimental and clinical data reporting the preventive activity of Ole on various pathological conditions associated with a bone loss, are indicative of a potential therapeutic role of this molecule in the prevention and treatment of cancer-related bone diseases. This paper provides a current overview regarding the molecular mechanisms and the experimental findings underpinning a possible clinical role of Ole in the prevention and development of cancer-related bone diseases.
- Published
- 2021
5. On the role of cystatin C in cancer progression
- Author
-
Marilena Crescimanno, Gaetano Leto, Carla Flandina, Leto, Gaetano, Crescimanno, Marilena, and Flandina, Carla
- Subjects
0301 basic medicine ,Metastasi ,Cysteine proteinase ,General Biochemistry, Genetics and Molecular Biology ,Cysteine Proteinase Inhibitors ,law.invention ,Metastasis ,Cathepsin ,03 medical and health sciences ,0302 clinical medicine ,law ,Neoplasms ,Medicine ,Animals ,Humans ,Cyst ,General Pharmacology, Toxicology and Pharmaceutics ,Neoplasm Metastasis ,Cystatin C ,Cancer ,biology ,business.industry ,Proteinase inhibitors ,General Medicine ,medicine.disease ,030104 developmental biology ,030220 oncology & carcinogenesis ,Cancer research ,biology.protein ,Disease Progression ,Settore BIO/14 - Farmacologia ,Suppressor ,business ,Function (biology) - Abstract
Cystatin C (Cyst C) is an endogenous inhibitor of lysosomal cysteine proteinases, which has been shown to play a role in several normal and pathological processes. Interestingly, a growing number of experimental and clinical studies suggest that this inhibitor also appears to be implicated in the malignant progression of various human tumors. However, the role of Cyst C in malignant diseases is still controversial as these studies have highlighted that this protein may function either as tumor suppressor or tumor promoter. The specific mechanisms underlying these opposing effects at present remain murky and are the subject of many current investigations. On the other hand, a complete knowledge of these mechanisms is of clinical interest in order to develop new, effective antitumor treatments based on the appropriate use of natural and/or synthetic cysteine proteinase inhibitors. This paper discusses the current findings regarding the role of Cyst C in cancer progression and the clinical implications emerging from these studies.
- Published
- 2018
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.